PHAT - Phathom Pharmaceuticals reports FY results March, 19 2020 08:41 AM Phathom Pharmaceuticals Inc. Phathom Pharmaceuticals (NASDAQ:PHAT): FY GAAP EPS of -$22.45.Cash and cash equivalents of $243.8MPress ReleaseMore news on: Phathom Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,